An RCT of a decision aid about taking aspirin to prevent cancer

SEMINAR | An RCT of a decision aid about taking aspirin to prevent cancer

SHAKIRA MILTON
PHD CANDIDATE
UNIVERSITY OF MELBOURNE CENTRE FOR CANCER RESEARCH

Aspirin reduces a person’s risk of developing and dying from bowel cancer by 25% and 33% respectively. Australian aspirin guidelines were published without a plan to implement them into practice. Decision aids are interventions designed to facilitate a discussion between a clinician and patient and communicate the harms and benefits of making a healthcare decision. The Should I Take Aspirin? (SITA) trial aimed to trial a decision aid with co-primary outcomes including uptake of aspirin and supporting informed choices for patients.

Shakira Milton is an early career researcher and PhD candidate working within screening, prevention, and early diagnosis of cancer. Her PhD has a particular focus on bowel cancer, patient experience and decision aid development. She has spent the last two-years working on an RCT of a decision aid to reduce colorectal cancer risk with aspirin. This project also has a qualitative component where participants and clinicians in the trial will provide feedback on trial implementation and our novel teletrial design. After completing her PhD she’d like to conduct implementation trials in cancer.